Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jaip.2021.04.029 | DOI Listing |
Publication Analysis
Top Keywords
reply "mepolizumab
4
"mepolizumab patients
4
patients eosinophilic
4
eosinophilic granulomatosis
4
granulomatosis polyangiitis
4
polyangiitis remission
4
remission dose?"
4
reply
1
patients
1
eosinophilic
1
Similar Publications
Mepolizumab for the Treatment of Eosinophilic Cystitis: Reply.
J Investig Allergol Clin Immunol
July 2024
National Reference Center for Hypereosinophilic Syndromes, CEREO, France; Université Paris-Saclay, Assistance Publique - Hôpitaux de Paris, Department of Internal Medicine, Ambroise Paré Hospital, Boulogne-Billancourt, France.
Reply: SOCS3 gene responsiveness to alarmins in eosinophils of mepolizumab-treated patients is as yet of unknown biological significance.
Eur Respir J
July 2022
Laboratory of Cellular and Molecular Immunology, GIGA Institute and Faculty of Veterinary Medicine, Liege University, Liege, Belgium
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!